Delivery Order SPE2DB22D3501-SPE2DB22FTV54
Award Date 9/7/22
Potential Completion Date 9/28/22
Potential Value $103K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $28,471.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, with a completion date of January 8, 2024. This is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $227,924.70 firm fixed price contract is for the delivery of REVLIMID 10 MG CAPSULE 100S pharmaceutical products. The contract has an end date of October 14, 2022 and was awarded on September 22, 2022. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S. government...
- The Defense Logistics Agency awarded a $267,465.18 delivery order to AmerisourceBergen Drug Corp for REVLIMID 10 mg capsules (100-count units) under a firm fixed-price contract. The order, issued on May 29, 2025, is scheduled for completion by June 20, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $82,961.12 to Amerisourcebergen Drug Corporation for the provision of 4561312422 REVLIMID 10 MG CAPSULE 28S. The firm fixed price order calls for the delivery of pharmaceutical products to a location in Conshohocken, Pennsylvania by July 13, 2023 in support of Department of Defense requirements. Amerisourcebergen will serve as the prime contractor on this delivery order placed against an unspecified governmentwide acquisition...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,561,277,335 units of the pharmaceutical product REVLIMID 25 MG CAPSULE 100S. The $107,931.18 order has a completion date of July 10, 2023 and was awarded on June 15, 2023. Amerisourcebergen Drug Corp has an existing indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical...
- The Defense Logistics Agency awarded a $14,122 delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical REVLIMID 10 MG. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery by August 22, 2023 in support of DLA programs. As a top 100 Defense Department contractor, Amerisourcebergen will likely distribute the medication through its commercial supply chain to military treatment facilities and...
- The Defense Logistics Agency awarded a $10,254 firm fixed price delivery order to AmerisourceBergen Drug Corp for REVLIMID 25 mg capsules (21-count units) on December 1, 2025, with completion scheduled for December 22, 2025. This non-set-aside award was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $215,824.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561924650 REVLIMID 10 MG CAPSULE 100S. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility in performance of the contract through September 13, 2023. The Defense Logistics Agency supports Department of Defense procurement programs by sourcing medical supplies and pharmaceuticals....
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product REVLIMID 10 MG CAPSULE 28S. The contract has a ceiling value of $163,311.98 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract does not have a set-aside designation and has an ultimate completion date of July 5, 2024. Amerisourcebergen holds a larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,560 units of REVLIMID 10 MG CAPSULE 100S. The order, valued at $107,912.38, has a completion date of May 3, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was not...